✦ LIBER ✦

A Randomized, Multicenter, Open-Label Phase 3 Study to Evaluate the Safety and Efficacy of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis

✍ Scribed by Jeffrey S. Hyams; Lakshmi Damaraju; Marion Blank; Jewel Johanns; Cynthia Guzzo; Harland S. Winter; Subra Kugathasan; Stanley A. Cohen; James Markowitz; Gigi Veereman; Wallace Crandall; Robert Baldassano; Anne M. Griffiths

Book ID: 119432352
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 519 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(11)60505-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Open-Label, Parallel Group

A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Proactive Management in Pediatric Subjects with Moderate to Severe Atopic Dermatitis

✍ Fukuie, Tatsuki; Nomura, Ichiro; Narita, Masami; Suzuki, Tsukasa; Tajima, Iwao; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A randomized, open-label study to evalua

A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in korean patients with hypercholesterolemia

✍ Sungha Park; Hyun-Jae Kang; Se-Joong Rim; Jong-Won Ha; Byung-Hee Oh; Namsik Chun 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 913 KB

A randomized study to evaluate the effic

A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis

✍ Lebwohl, Mark G.; Kircik, Leon; Callis Duffin, Kristina; Pariser, David; Hooper, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Efficacy and safety of infliximab vs. me

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

✍ J. Barker; M. Hoffmann; G. Wozel; J.-P. Ortonne; H. Zheng; H. van Hoogstraten; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

943d A Phase 2/3 Randomized, Placebo-con

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Efficacy and safety of adalimumab for mo

Efficacy and safety of adalimumab for moderate to severe hidradenitis suppurativa: Results from the open-label phase of a 52-week phase II, randomized, study

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB